Related Experiment Videos
Cholesterol and cancer: comparative biochemistry and selective toxicity
1Section of Cardiology, West Virginia University Hospital, Morgantown 26506.
Medical Hypotheses
|February 1, 1989
Summary
Cancer cells exhibit altered cholesterol biosynthesis regulation compared to normal cells, often losing negative feedback control. This study explores the cholesterol-cancer link and proposes a model based on comparative biochemistry to exploit these regulatory differences.
Area of Science:
- Biochemistry
- Cancer Biology
- Molecular Oncology
Background:
- Neoplastic cells exhibit distinct regulation of cholesterol biosynthesis compared to normal cells.
- Transformed cells frequently display a loss of negative feedback control in the cholesterol biosynthesis pathway.
- Understanding these regulatory differences is crucial for cancer research.
Purpose of the Study:
- To elucidate the relationship between cholesterol and cancer.
- To present a novel model for cancer research based on comparative biochemistry.
- To exploit the differential regulation of cholesterol biosynthesis between normal and neoplastic cells.
Main Methods:
- Comparative biochemical analysis of cholesterol biosynthesis pathways.
- Modeling based on Adrien Albert's second principle of selectivity.
- Investigation of regulatory differences in normal versus cancer cells.
Main Results:
- Abundant evidence supports distinct cholesterol biosynthesis regulation in normal and neoplastic cells.
- Loss of negative feedback control is a characteristic of transformed cells.
- The proposed model leverages these biochemical differences.
Conclusions:
- The regulation of cholesterol biosynthesis is a key differentiator between normal and neoplastic cells.
- Comparative biochemistry offers a viable approach to understanding and potentially targeting cancer.
- Exploiting the loss of negative feedback in cancer cells presents a promising research avenue.